Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,159,000 | -253,000 | -2,499,000 | -1,152,000 | -1,211,000 |
| Depreciation Amortization | 604,000 | 304,000 | 1,308,000 | 1,002,000 | 681,000 |
| Income taxes - deferred | -150,000 | -106,000 | -1,064,000 | -1,214,000 | -1,258,000 |
| Accounts receivable | N/A | N/A | 334,000 | N/A | N/A |
| Other Working Capital | -137,000 | -349,000 | 1,355,000 | 1,007,000 | 913,000 |
| Other Operating Activity | 1,021,000 | 259,000 | 2,156,000 | 974,000 | 949,000 |
| Operating Cash Flow | $179,000 | $-145,000 | $1,590,000 | $617,000 | $74,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200,000 | -137,000 | -480,000 | -361,000 | -241,000 |
| Net Acquisitions | N/A | N/A | -7,000 | -7,000 | -7,000 |
| Purchase Of Investment | -6,000 | -4,000 | -1,000 | -2,000 | -4,000 |
| Sale Of Investment | N/A | N/A | 4,000 | N/A | 3,000 |
| Other Investing Activity | 689,000 | 322,000 | 1,140,000 | 858,000 | 590,000 |
| Investing Cash Flow | $483,000 | $181,000 | $656,000 | $488,000 | $341,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,451,000 | 2,451,000 | N/A | N/A | N/A |
| Debt Repayment | -3,152,000 | -3,152,000 | -1,369,000 | -661,000 | -296,000 |
| Other Financing Activity | -60,000 | -5,000 | -118,000 | -115,000 | -40,000 |
| Financing Cash Flow | $-761,000 | $-706,000 | $-1,487,000 | $-776,000 | $-336,000 |
| Exchange Rate Effect | -65,000 | 12,000 | -123,000 | -269,000 | -185,000 |
| Beginning Cash Position | 2,834,000 | 2,834,000 | 2,198,000 | 2,198,000 | 2,198,000 |
| End Cash Position | 2,670,000 | 2,176,000 | 2,834,000 | 2,258,000 | 2,091,000 |
| Net Cash Flow | $-164,000 | $-658,000 | $636,000 | $60,000 | $-107,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 179,000 | -145,000 | 1,590,000 | 617,000 | 74,000 |
| Capital Expenditure | -258,000 | -139,000 | -548,000 | -406,000 | -284,000 |
| Free Cash Flow | -79,000 | -284,000 | 1,042,000 | 211,000 | -210,000 |